Biopharmaceutical CMO and CRO Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2021 to 2027

The Global Biopharmaceutical CMO and CRO Market size was valued at 27.20 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 7% from 2021 to 2027.

Biopharmaceutical CMOs and CROs are an integral part of the biopharmaceutical industry. CMOs and CROs are directly connected and influenced by the biopharmaceutical industry. CMO refers to a contract manufacturing organization that establishes a manufacturing plant and produces biopharmaceuticals on a large scale under contract. These organizations are manufacturing professionals that save contractors money and time and provide efficient output. CRO refers to a contract research organization that undertakes various research and development activities designated by the contractor and assists in the development of new and innovative drugs. Growing consumer demand for biopharmaceuticals has contributed to the rapid growth of the biopharmaceutical industry. Biopharmaceuticals are growing rapidly worldwide and account for more than 20% of the total pharmaceutical industry.

Market Segments

By Service

• Contract Manufacturing
• Contract Research

By Source

• Mammalian
• Non-Mammalian

By Product

• Biologics
• Biosimilars

Key Players

• Lonza
• JRS Pharma
• Samsung Biologics
• CMC Biologics
• TOYOBO Co. Ltd.
• RentschlerBiotechnologie
• FUJIFILM Diosynth Biotechnologies
• WuXi Biologics
• Patheon

Scope of the Report

The research study analyzes the global Biopharmaceutical CMO and CRO industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Biopharmaceutical CMO and CRO Market Report

1. What was the Biopharmaceutical CMO and CRO Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027).

2. What will be the CAGR of the Biopharmaceutical CMO and CRO Market during the forecast period (2021-2027)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
4. Which manufacturer/vendor/players in the Biopharmaceutical CMO and CRO Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.